Angiotech to acquire Cohesion Technologies for $42 million
This article was originally published in Clinica
Executive Summary
Angiotech Pharmaceuticals (Vancouver, Canada) is to acquire the California-based biosurgical materials company, Cohesion Technologies, in an all-stock transaction valued at about $42m. The deal, scheduled for completion in the first quarter of 2003, will provide Angiotech with an entry into the $1.5bn biosurgical materials market.